These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34995578)

  • 21. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
    Hao J; Chen C; Huang K; Huang J; Li J; Liu P; Huang H
    Eur J Pharmacol; 2014 Dec; 745():152-65. PubMed ID: 25310908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
    Shum M; Bellmann K; St-Pierre P; Marette A
    Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
    Tripathy S; Jump DB
    J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin Resistance in Apolipoprotein M Knockout Mice is Mediated by the Protein Kinase Akt Signaling Pathway.
    Yao S; Zhang J; Zhan Y; Shi Y; Yu Y; Zheng L; Xu N; Luo G
    Endocr Metab Immune Disord Drug Targets; 2020; 20(5):771-780. PubMed ID: 31702495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
    Song JX; Ren JY; Chen H
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
    Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
    Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.
    Sanvee GM; Panajatovic MV; Bouitbir J; Krähenbühl S
    Biochem Pharmacol; 2019 Jun; 164():23-33. PubMed ID: 30796916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
    Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
    Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.
    Mans RA; McMahon LL; Li L
    Neuroscience; 2012 Jan; 202():1-9. PubMed ID: 22192838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: Role of the small G protein Rac1.
    Ferri N; Marchianò S; Lupo MG; Trenti A; Biondo G; Castaldello P; Corsini A
    Pharmacol Res; 2017 Aug; 122():96-104. PubMed ID: 28554582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
    Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
    Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone methyltransferase G9a modulates hepatic insulin signaling via regulating HMGA1.
    Xue W; Huang J; Chen H; Zhang Y; Zhu X; Li J; Zhang W; Yuan Y; Wang Y; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):338-346. PubMed ID: 29101051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
    Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
    Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway.
    Qi XF; Zheng L; Lee KJ; Kim DH; Kim CS; Cai DQ; Wu Z; Qin JW; Yu YH; Kim SK
    Cell Death Dis; 2013 Feb; 4(2):e518. PubMed ID: 23449454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
    Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
    Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.
    Lamming DW; Ye L; Katajisto P; Goncalves MD; Saitoh M; Stevens DM; Davis JG; Salmon AB; Richardson A; Ahima RS; Guertin DA; Sabatini DM; Baur JA
    Science; 2012 Mar; 335(6076):1638-43. PubMed ID: 22461615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-191 blocking the translocation of GLUT4 is involved in arsenite-induced hepatic insulin resistance through inhibiting the IRS1/AKT pathway.
    Li W; Wu L; Sun Q; Yang Q; Xue J; Shi M; Tang H; Zhang J; Liu Q
    Ecotoxicol Environ Saf; 2021 Jun; 215():112130. PubMed ID: 33743404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DhHP-6 ameliorates hepatic oxidative stress and insulin resistance in type 2 diabetes mellitus through the PI3K/AKT and AMPK pathway.
    Wang K; Liang Y; Su Y; Wang L
    Biochem J; 2020 Jun; 477(12):2363-2381. PubMed ID: 32510127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
    Hsieh CT; Chuang JH; Yang WC; Yin Y; Lin Y
    Cell Signal; 2014 Jul; 26(7):1400-8. PubMed ID: 24650522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.